Nicotine Polacrilex Lozenge
Product Images NDC 45802-344

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nicotine Polacrilex (NDC 45802-344). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Israel Pharmaceuticals Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Wallet_card (Image 01)

An informational wallet card providing contact phone numbers for quitting help, listing the American Lung Association, American Cancer Society, and American Heart Association. It also suggests contacting a quitting buddy or friend who has quit smoking.*

FDA Label Image

Wallet‑_card (Image 02)

An instructional wallet card with the heading "My most important reasons to quit smoking are:" followed by six blank lines for personal entries. The card is bordered and designed for individuals to write motivational reasons to stop smoking.*

FDA Label Image

Smoke_free_logo (Image 03)

FDA Label Image

Upc_example (Image 04)

Nicotine Polacrilex 2 mg lozenge by Padagis Israel Pharmaceuticals Ltd. The image shows a close-up of a barcode with the text 'EXAMPLE UPC ONLY' printed above it in red, and the UPC number below.*

FDA Label Image

Stickers (Image 05)

An instructional diagram with four colored boxed reminders for using Nicotine Polacrilex lozenges, detailing the recommended frequency of lozenge use at different time points: Step 1 at week 1 (1 lozenge every 1 to 2 hours), Step 2 at week 7 (1 lozenge every 2 to 4 hours), Step 3 at week 10 (1 lozenge every 4 to 8 hours), and an 'EX-SMOKER' mark 12 weeks after the quit date.*

FDA Label Image

Padagis Nicotine Lozenge 2mg Mint Carton Image 1 Of 2 (Carton Image 1 Of 2)

Packaging label for Nicotine Polacrilex Lozenge 2 mg by Padagis Israel Pharmaceuticals Ltd. The front panel highlights it as a stop smoking aid with mint flavor and includes 72 lozenges in 3 QuitTube containers of 24 each. The label includes images of a white lozenge and a blue bottle with a tamper-evident seal.*

FDA Label Image

Padagis Nicotine Lozenge 2 mg Mint Carton Image 2 Of 2 (Carton Image 2 Of 2)

Drug Facts panel for Nicotine Polacrilex 2 mg lozenge details active ingredient, purpose as stop smoking aid, uses including reducing withdrawal symptoms, pertinent warnings and precautions, directions for use, and other information such as inactive ingredients and storage instructions. Includes guidance on dosage schedules and restrictions for use in children under 18.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.